Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab
Pérez de Llano, Luis A., Dacal Rivas, David, Cosío, Borja G.Journal:
Allergy
DOI:
10.1111/all.14035
Date:
October, 2019
File:
PDF, 256 KB
2019